Bettina Bisig

1.9k total citations
64 papers, 920 citations indexed

About

Bettina Bisig is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Bettina Bisig has authored 64 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pathology and Forensic Medicine, 25 papers in Oncology and 14 papers in Immunology. Recurrent topics in Bettina Bisig's work include Lymphoma Diagnosis and Treatment (27 papers), Viral-associated cancers and disorders (13 papers) and T-cell and Retrovirus Studies (7 papers). Bettina Bisig is often cited by papers focused on Lymphoma Diagnosis and Treatment (27 papers), Viral-associated cancers and disorders (13 papers) and T-cell and Retrovirus Studies (7 papers). Bettina Bisig collaborates with scholars based in Switzerland, France and Belgium. Bettina Bisig's co-authors include Laurence de Leval, Philippe Gaulard, Edoardo Missiaglia, Philippe Delvenne, Jacques Boniver, Marie Parrens, Céline Bossard, Audrey Letourneau, Caroline Thielen and David Vallois and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Bettina Bisig

58 papers receiving 910 citations

Peers

Bettina Bisig
Deok‐Hwan Yang South Korea
Chung‐Che Chang United States
Daryl Tan Singapore
Jae‐Sook Ahn South Korea
Edward H. Lipford United States
Taiga Nishihori United States
Deok‐Hwan Yang South Korea
Bettina Bisig
Citations per year, relative to Bettina Bisig Bettina Bisig (= 1×) peers Deok‐Hwan Yang

Countries citing papers authored by Bettina Bisig

Since Specialization
Citations

This map shows the geographic impact of Bettina Bisig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bettina Bisig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bettina Bisig more than expected).

Fields of papers citing papers by Bettina Bisig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bettina Bisig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bettina Bisig. The network helps show where Bettina Bisig may publish in the future.

Co-authorship network of co-authors of Bettina Bisig

This figure shows the co-authorship network connecting the top 25 collaborators of Bettina Bisig. A scholar is included among the top collaborators of Bettina Bisig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bettina Bisig. Bettina Bisig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bisig, Bettina, et al.. (2024). Cytokine-pathway blockers worsen mycosis fungoides masquerading as psoriasis. JAAD Case Reports. 48. 98–102. 3 indexed citations
2.
Bisig, Bettina, Karine Lefort, Sylvain Carras, & Laurence de Leval. (2024). Clinical use of circulating tumor DNA analysis in patients with lymphoma. Human Pathology. 156. 105679–105679.
3.
Bisig, Bettina, Baptiste Guey, Edoardo Missiaglia, et al.. (2024). Follicular Lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases. Modern Pathology. 37(4). 100440–100440. 1 indexed citations
4.
Leval, Laurence de, Bettina Bisig, Jean‐Philippe Brouland, et al.. (2024). Primary diffuse large B-cell lymphoma of the central nervous system identified with CSF biomarkers. BMC Neurology. 24(1). 250–250. 1 indexed citations
5.
Veloza, Luis, David Vallois, Vimel Rattina, et al.. (2023). TCL-473 Role of Microsatellite Instability in the Oncogenesis of Primary Intestinal T-Cell Lymphomas. Clinical Lymphoma Myeloma & Leukemia. 23. S471–S471.
6.
Poullot, Elsa, François Lemonnier, Bettina Bisig, et al.. (2023). Angioimmunoblastic T‐cell lymphoma and Kaposi sarcoma: A fortuitous collision?. Histopathology. 84(3). 556–564. 1 indexed citations
7.
Missiaglia, Edoardo, Olivier Michielin, Petros Tsantoulis, et al.. (2023). Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma. International Journal of Molecular Sciences. 24(5). 4520–4520. 7 indexed citations
8.
Leval, Laurence de & Bettina Bisig. (2023). What is new in the classification of peripheral T cell lymphomas?. PubMed. 44(S3). 128–135.
9.
10.
Anchisi, Sandro, Anita Wolfer, Bettina Bisig, et al.. (2023). Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient. Cancer Biology & Therapy. 24(1). 2193116–2193116. 2 indexed citations
11.
Nicolae, Alina, Justine Bouilly, Virginie Fataccioli, et al.. (2022). Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations. Modern Pathology. 35(8). 1126–1136. 24 indexed citations
12.
Bisig, Bettina, Anne Cairoli, Olivier Gaide, et al.. (2022). Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 481(4). 653–657. 2 indexed citations
13.
Veloza, Luis, Chun‐Yi Tsai, Bettina Bisig, et al.. (2021). EBV-positive large B-cell lymphoma with an unusual intravascular presentation and associated haemophagocytic syndrome in an HIV-positive patient: report of a case expanding the spectrum of EBV-positive immunodeficiency-associated lymphoproliferative disorders. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 480(3). 699–705. 4 indexed citations
14.
Berezowska, Sabina, Karine Lefort, Kalliopi Ioannidou, et al.. (2021). Postmortem Cardiopulmonary Pathology in Patients with COVID-19 Infection: Single-Center Report of 12 Autopsies from Lausanne, Switzerland. Diagnostics. 11(8). 1357–1357. 9 indexed citations
15.
Foukas, Periklis, Bettina Bisig, & Laurence de Leval. (2020). Recent advances in upper gastrointestinal lymphomas: molecular updates and diagnostic implications. Histopathology. 78(1). 187–214. 11 indexed citations
16.
Bongiovanni, Massimo, Gerasimos P. Sykiotis, Stefano La Rosa, et al.. (2019). Macrofollicular Variant of Follicular Thyroid Carcinoma: A Rare Underappreciated Pitfall in the Diagnosis of Thyroid Carcinoma. Thyroid. 30(1). 72–80. 28 indexed citations
17.
Letourneau, Audrey, et al.. (2018). Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 473(4). 505–511. 48 indexed citations
18.
Dupouy, Diego, et al.. (2016). Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancer. Scientific Reports. 6(1). 20277–20277. 33 indexed citations
19.
Savic, Spasenija, Joachim Diebold, Anne‐Katrin Zimmermann, et al.. (2015). Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended. Lung Cancer. 89(2). 104–109. 61 indexed citations
20.
Hubert, Pascale, Jean Doyen, Mohammad Arafa, et al.. (2010). Local Applications of GM‐CSF Induce the Recruitment of Immune Cells in Cervical Low‐Grade Squamous Intraepithelial Lesions. American Journal of Reproductive Immunology. 64(2). 126–136. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026